Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.28 EUR | +0.86% | +1.21% | +4.31% |
May. 28 | FMC briefly burdened by research success in the fight against diabetes | DP |
May. 24 | FMC, Fresenius and Davita rise after Ozempic news | DP |
Sales 2024 * | 22.19B 24.06B | Sales 2025 * | 23.33B 25.3B | Capitalization | 16.49B 17.89B |
---|---|---|---|---|---|
Net income 2024 * | 1.38B 1.5B | Net income 2025 * | 1.72B 1.87B | EV / Sales 2024 * | 1.3 x |
Net Debt 2024 * | 12.44B 13.49B | Net Debt 2025 * | 11.7B 12.69B | EV / Sales 2025 * | 1.21 x |
P/E ratio 2024 * |
11.8
x | P/E ratio 2025 * |
9.38
x | Employees | 190,863 |
Yield 2024 * |
3.23% | Yield 2025 * |
3.55% | Free-Float | 73.04% |
Latest transcript on Fresenius SE & Co. KGaA
1 day | +0.86% | ||
1 week | +1.21% | ||
1 month | +4.68% | ||
3 months | +13.49% | ||
6 months | +0.65% | ||
Current year | +4.31% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Sen
CEO | Chief Executive Officer | 55 | 21-04-11 |
Sara Hennicken
DFI | Director of Finance/CFO | 44 | 18-12-31 |
Michael Moser
CMP | Compliance Officer | - | 23-07-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Diekmann
BRD | Director/Board Member | 69 | 15-05-19 |
Director/Board Member | 63 | 16-05-12 | |
Konrad Kölbl
BRD | Director/Board Member | 64 | 07-07-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.26% | 2 M€ | +13.56% | - | |
1.05% | 962 M€ | -.--% | - | |
1.01% | 79 M€ | -.--% | ||
0.92% | 0 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 29.28 | +0.86% | 2,009,810 |
24-05-30 | 29.03 | +0.10% | 715,062 |
24-05-29 | 29 | -0.79% | 984,889 |
24-05-28 | 29.23 | +0.10% | 843,061 |
24-05-27 | 29.2 | +0.93% | 650,374 |
Delayed Quote Xetra, May 31, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.31% | 17.88B | |
+25.52% | 88.99B | |
-24.52% | 74.82B | |
-5.56% | 25.03B | |
-14.25% | 16.43B | |
+2.97% | 15.77B | |
+79.20% | 13.21B | |
+70.11% | 13.08B | |
+40.44% | 12.9B | |
+24.51% | 12.7B |
- Stock Market
- Equities
- FRE Stock